Bilcare Research AG announces acquisition of a new site in Singapore
Bilcare Research AG after having consolidated its leadership position in Europe, USA and Asia, widens its global reach with the acquisition of a manufacturing location for high barrier films for the pharmaceutical industry in Singapore. The new member of the group will operate under the name of Bilcare Research Singapore Pte. Ltd.
“We do now offer the Pharma market a truly global footprint having production sites in Europe, USA and Asia”, says Andreas Pfefferle, Global Business Unit Head for Pharma Packaging Innovations. “The new facility and additional capacity combined with Bilcare’s superior customer experience, gives us a more competitive edge to support and expand our customer base in Asia, particularly looking at the exponential growing Chinese market. This acquisition fits in well with our Asia expansion strategy to reach customers largely in China and elsewhere in Asia”.
ABOUT BILCARE RESEARCH
Bilcare is a global leader and an innovation-led packaging solutions provider that partners with the pharmaceutical industry to improve patient healthcare outcomes. We endeavor to deliver effective and affordable solutions that enhance the speed and quality of drug discovery and help build and protect brands by ensuring the delivery of genuine medicines to patients. Bilcare PPI offers Innovative Pharmaceutical Packaging Solutions comprising of a wide range of specialty Polymer Films and Aluminum Foils mainly used for packaging of solid dosage pharmaceutical products.
- Previous ADITYA BIRLA BIZLABS LAUNCHES 20 DAY PROGRAM FOR STARTUPS TO SCALE UP
- Next Aliens Group Leaves Customers Pleased with its Project Aliens Space Station